Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

ClinicalTrials.gov ID: NCT05536297

Public ClinicalTrials.gov record NCT05536297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 9:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension (OLE) Phase 3 Trial to Assess the Safety of Intravitreal Administration of Avacincaptad Pegol (Complement C5 Inhibitor) in Patients With Geographic Atrophy Who Previously Completed Phase 3 Study ISEE2008 (GATHER2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess long-term safety of avacincaptad pegol intravitreal administration for patients with geographic atrophy (GA) who completed Study ISEE2008 (GATHER2) through the Month 23 visit on study treatment (either avacincaptad pegol or Sham).

Study identification

NCT ID
NCT05536297
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
278 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 26, 2022 (Actual)
Primary completion
Apr 10, 2025 (Actual)
Completion
Apr 10, 2025 (Actual)
Last update posted
May 18, 2026

2022 – 2025

United States locations

U.S. sites
53
U.S. states
21
U.S. cities
52
Facility City State ZIP Site status
Retinal Diagnostic Center Campbell California 95008 —
Eye Medical Center of Fresno Fresno California 93720 —
Retina Consultants of Orange County Fullerton California 92835 —
Jacobs Retina Center at The Shiley Eye Institute USCD La Jolla California 92093 —
Jules Stein Eye Institute David Geffen School of Medicine Los Angeles California 90095 —
Doheny Eye Center, UCLA Pasadena California 91105 —
Retina Consultants of Southern California Redlands California 92374 —
Orange County Retinal Med Group Santa Ana California 92705 —
University of Colorado Aurora Colorado 80045 —
Retina Consultants of Southern CO Colorado Springs Colorado 80909 —
Colorado Retina Associates, PC Lakewood Colorado 80228 —
Rand Eye Institute Deerfield Beach Florida 33064 —
Retina Group of Florida Fort Lauderdale Florida 33308 —
Florida Eye Associates Melbourne Florida 32901 —
Retina Care Specialists Palm Beach Gardens Florida 33410 —
Retina Associates of Sarasota Sarasota Florida 34233 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33711 —
East Florida Eye Institute Stuart Florida 34994 —
Southern Vitreoretinal Associates Tallahassee Florida 32308 —
Center for Retina & Macula Disease Winter Haven Florida 33880 —
Southeast Retina Center P.C. Augusta Georgia 30909 —
Retina Consultants of Hawaii, Inc. ‘Aiea Hawaii 96701 —
Illinois Eye Center Peoria Illinois 61615 —
Vitreo Retinal Consultants & Surgeons Wichita Kansas 67214 —
Ochsner Clinic Foundation New Orleans Louisiana 70124 —
The Retina Group of Washington Chevy Chase Maryland 20815 —
Cumberland Valley Retina Consultants Hagerstown Maryland 21740 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Retina Research Institute at New England Retina Springfield Massachusetts 01107 —
Vitreoretinal Associates PC Worcester Massachusetts 01605 —
Sierra Eye Associates Reno Nevada 89502 —
Retina Vitreous Surgeons of Central New York Liverpool New York 13088 —
Ophthalmic Consultants of Long Island Oceanside New York 11572 —
Retina Associates of Western NY Rochester New York 14620 —
Western Carolina Retinal Associates Asheville North Carolina 28803 —
Retina & Vitreous Center of Southern Oregon, PC Ashland Oregon 97520 —
Retina Northwest PC Portland Oregon 97221 —
Eye Health Northwest Portland Oregon 97225 —
Mid Atlantic Retina - Wills Eye Institute Philadelphia Pennsylvania 19107 —
Associates in Ophthalmology West Mifflin Pennsylvania 15122 —
Retina Research of Beaufort Beaufort South Carolina 29902 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Southeastern Retina Associates, PC Knoxville Tennessee 37922 —
Retina Research Institute of Texas, LLC Abilene Texas 79606 —
Southwest Retina Specialists Amarillo Texas 79106 —
Austin Retina Associates Austin Texas 78705 —
Retina Foundation of the Southwest Dallas Texas 75231 —
Retina Center of Texas Southlake Texas 76092 —
Retina Consultants of Houston The Woodlands Texas 77384 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —
Retina Associates of Utah PC Salt Lake City Utah 84107 —
Pacific Northwest Retina Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05536297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05536297 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →